ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Obesity
Foot Ulcer
Overweight

Diabetes trials near Barcelona, CT, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Barcelona, Spain and 59 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 178 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 47 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Barcelona, Spain and 78 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: Placebo
Biological: TCD601

Phase 2

ITBMed

Barcelona, Spain and 26 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Barcelona, Spain and 119 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or ov...

Not yet enrolling
Type 1 Diabetes
Overweight
Drug: Tirzepatide
Drug: Placebo

Phase 3

Lilly
Lilly

Barcelona, Barcelona [Barcelona], Spain and 147 other locations

medical purpose population, i.e., in individuals with unknown diabetes risk. Additionally, this investigation will serve as a pivotal perfor...

Active, not recruiting
Pre-diabetes
Undiagnosed Diseases
Device: Near-infrared (NIR)
Glyconics

Barcelona, Spain

The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargin...

Active, not recruiting
Diabetes, Type 2
Drug: Insulin glargine
Drug: Insulin icodec

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 69 other locations

Locations recently updated

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling
Type 2 Diabetes (T2D)
Drug: Placebo (NNC0487-0111 oral)
Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 102 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems